Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Privately-owned Grünenthal estimates the Nebido brand will add about €100 million to its EBITDA in 2023.
Grünenthal has agreed to acquire testosterone treatment NebidoTM and...
Could The Long Deckline In Biotechnology M&A Be Ending
There were at least 14 biopharma purchases totaling $50 million or more between April and June, which is at least twice as many as...
No Rush In Indian Generic Drug Firms To Launch COVID Products
Indian generic drugmakers are delaying more investments in COVID-related drugs after making gains in the last two years, according to certain pharmaceutical industry insiders.
BDR...
Gerresheimer raises revenue guidance for 2022 to double-digit growth after strong first quarter
Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, made a strong start to...
Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform
Metagenomi, a genetic medicines company with a versatile portfolio of next-generation gene editing tools, today announced the completion of an up-sized and oversubscribed $175...
Indian Pharma Industry To Grow By 9-11% In FY22- ICRA
Driven by the push from emerging as well as domestic markets in the upcoming quarters, the Indian Pharma industry in the Financial Year-22 is...
IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...